USPTO serial 99796839
SOLESIS
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- SOUNDAR, SHERYL CHRISTINA
- Law office
- TMO LAW OFFICE 136
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SOLESIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Telford, PA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian P. Gregg
Brian P. Gregg McNees Wallace & Nurick100 Pine StreetHarrisburg, PA 17108United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Combination natural and synthetic biocompatible materials consisting primarily of synthetic materials sold as an integral component of surgical implants, interventional delivery systems, pharmaceutical preparations, and biomanufacturing preparations for medical purposes, namely, implantable medical textiles, polymeric textiles, implantable polymers, and polymeric biocontainment systems composed of natural and synthetic biomaterials | ACTIVE | — |
| 010 | Synthetic materials sold as an integral component of surgical implants and interventional delivery systems | ACTIVE | — |
| 042 | Research, design and development services in the field of medical devices, pharmaceuticals, and biological therapeutics; design and development of medical devices, pharmaceuticals, and biomanufacturing products and their manufacturing methods; Product quality testing, namely, medical device, pharmaceutical, and biomanufacturing product evaluation services; Research, design and development of new medical devices, pharmaceuticals, and biological therapeutics for others; Medical research in the field of synthetic implants; Medical research relating to synthetic tissue; Medical research in the field of controlled release; Medical research relating to pharmaceutical delivery; Medical research related to biologically derived therapies; Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 26, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 26, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 26, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 30, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 30, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 30, 2026 | NWAP | NEW APPLICATION ENTERED | — |